首页> 外文期刊>Trends in Ecology & Evolution >Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis
【24h】

Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis

机译:粪便微生物移植不同模式溃疡性结肠炎的临床缓解:META分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Ulcerative colitis (UC) is a chronic, recurrent and destructive disease of the gastrointestinal tract. Faecal microbiota transplantation (FMT) is a therapeutic measure in which faecal microbiota from healthy people is transplanted into patients. Aim To systematically evaluate the safety and effectiveness of treating UC with different modes of FMT. Methods Seven databases were searched by two independent researchers and studies related to randomized controlled trials were included in the analysis. Results Seven studies on UC involving 431 patients were included in the analysis. The results showed that FMT had better efficacy than placebo (OR = 2.29, 95% CI 1.48-3.53, P = 0.0002). Subgroup analyses of influencing factors showed that frozen faeces from multiple donors delivered via the lower gastrointestinal tract had a better curative effect than placebo (OR = 2.76, 95% CI 1.59-4.79, P = 0.0003; OR = 2.93, 95% CI 1.67-5.71, P = 0.0002; and OR = 2.70, 95% CI 1.67-4.37, P < 0.0001); the difference in efficacy between mixed faeces from a single donor transplanted through the upper gastrointestinal tract and placebo was not significant(P = 0.05, P = 0.09 and P = 0.98). The analysis of side effects showed no significant difference between FMT and placebo (P = 0.43). Conclusions It may be safe and effective to transplant frozen faeces from multiple donors through the lower gastrointestinal tract to treat UC.
机译:背景技术溃疡性结肠炎(UC)是胃肠道的慢性,复发性和破坏性疾病。粪便微生物会移植(FMT)是一种治疗措施,其中来自健康人的粪便微生物群被移植到患者中。旨在系统地评估用不同模式治疗UC的安全性和有效性。方法通过两个独立的研究人员搜查七个数据库,并在分析中包含与随机对照试验相关的研究。结果分析中涉及涉及431名患者的UC的七项研究。结果表明,FMT具有比安慰剂更好的疗效(或= 2.29,95%CI 1.48-3.53,P = 0.0002)。影响因素的亚组分析表明,通过较低胃肠道递送的多个供体的冷冻粪便具有比安慰剂(OR = 2.76,95%CI 1.59-4.79,P = 0.0003;或= 2.93,95%CI 1.67- 5.71,p = 0.0002;或= 2.70,95%CI 1.67-4.37,P <0.0001);从上胃肠道和安慰剂移植的单个供体之间的混合粪便之间的疗效差异不显着(p = 0.05,p = 0.09和p = 0.98)。副作用的分析显示FMT和安慰剂之间没有显着差异(P = 0.43)。结论从多个供体通过较低的胃肠道移植到胃肠道治疗UC可能是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号